Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CLDN19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COPB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM58 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MUC5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFTPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102723648 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ANO4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF114 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BST1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP1LC3B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GYPE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP13A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC31A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00644 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on